Peptides by goal · Hormones and sexual health
Peptides for libido and sexual health, ranked by evidence
Checked against our library and study pagesPublished by PepVault
Of the 6 compounds in our library linked to libido and sexual health, 4 have been studied in people for it (1 FDA-approved for a related use), none has animal or lab evidence only, and 2 rest on community reports alone. PT-141 ranks first, with 2 of our study pages in people on libido and sexual health.
Peptides and libido and sexual health
The libido peptides act on desire in the brain rather than on blood flow, which sets them apart from the erection drugs. One is an approved medicine for low sexual desire in women; the others are known from smaller trials or community use.
For libido, check who was studied (women with low desire, men with erectile problems) and whether the peptide was taken as needed or every day.

The 6 compounds, ranked by evidence
FDA-approved for a related use
1 compound
PT-141
#1 · FDA-approvedAn FDA-approved, as-needed treatment for low sexual desire in premenopausal women that acts through brain melanocortin receptors rather than blood flow (flibanserin/Addyi is the other, daily option). Small early studies in men showed erection effects. For libido and sexual health it sits on the top rung: the library records an FDA approval for a related use, and 2 of our study pages in people cover it.
What FDA approved it for, from the labels (read Nov 18, 2026): Vyleesi (injection) for low sexual desire that causes marked distress (acquired, generalized hypoactive sexual desire disorder) in premenopausal women; its label says it is not for men or to enhance sexual performance. PT-141: legal and regulatory status
PT-141: desire gains over placebo held across RECONNECT subgroupsOur study page: randomized trial in people, 1,202 people, 2022
Why it is here: its library entry lists “Sexual desire” and “CNS-based arousal” and 2 of our study pages are about this goal.
Studied in people
3 compounds
Melanotan II
#2 · Human studiesA broad-spectrum melanocortin agonist originally developed for sunless tanning. MT-2 stimulates melanocytes to produce melanin (it works without sun; UV exposure speeds and deepens the tan), increases libido through central nervous system pathways, and can reduce appetite. For libido and sexual health it has been studied in people: 1 of our study pages in people is about it.
Melanotan II: erections in 17 of 20 men with erectile dysfunctionOur study page: clinical trial in people, 20 people, 2000
Why it is here: its library entry lists “Libido boost” and 1 of our study pages is about this goal.
Enclomiphene
#3 · Human studiesAn oral medication that blocks estrogen's negative feedback at the hypothalamus, tricking your brain into producing more LH and FSH — which stimulates your body's own testosterone production. Commonly reported: better energy and libido over a few weeks as testosterone rises, mood changes such as irritability in some, and occasional visual disturbances that make some people stop. For libido and sexual health the trials in people that its library entry cites put it on this rung, though none of our study pages covers this goal yet.
The library’s research note “What Enclomiphene is built on” rests on studies in people.
Why it is here: .
Kisspeptin-10
#4 · Human studiesA hypothalamic neuropeptide that sits upstream of GnRH in your hormonal cascade — it's the signal that tells your brain to start producing reproductive hormones. Commonly reported: a libido or mood lift within hours of a dose for some, while many find the effects subtle or short-lived. For libido and sexual health the trials in people that its library entry cites put it on this rung, though none of our study pages covers this goal yet.
The library’s research note “What Kisspeptin-10 is built on” rests on studies in people.
Why it is here: .
Community reports only
2 compounds
HCG
#5 · Reports onlyHCG is the pregnancy hormone, and in men it does the job of luteinizing hormone: it tells the testes to keep making testosterone. Commonly reported: the testes keep, or regain, their size and fullness on TRT, a lift in libido and well-being for some, and estrogen-type effects such as puffiness or nipple tenderness, more so at higher doses. For libido and sexual health it rests on community reports: no study page of ours covers this goal, and the library lists it under .
Why it is here: .
Clomiphene
#6 · Reports onlyAn oral pill that blocks estrogen's signal in the brain, so the body makes more of its own LH and FSH, and with them testosterone and sperm. Commonly reported: more energy and libido over a few weeks, and in some, mood swings, hot flashes or visual spots, the side effect the label warns about. For libido and sexual health it rests on community reports: no study page of ours covers this goal, and the library lists it under .
Why it is here: .
How they differ
Route, dosing frequency and half-life as each library entry records them, for the 6 compounds in ranked order.
| Compound | Evidence | Route | Dosing frequency | Half-life |
|---|---|---|---|---|
| PT-141 | FDA-approved | SubQ injection | As needed, 1–2 hours before | ~2.7 hours |
| Melanotan II | Human studies | SubQ injection | Loading: 250mcg daily for 1-2 weeks. Maintenance: 250-500mcg 2-3x/week or as needed. | Unknown in humans |
| Enclomiphene | Human studies | Oral | Daily | ~10 hours |
| Kisspeptin-10 | Human studies | SubQ injection | Pulsatile — 2–3x/week | ~4 min |
| HCG | Reports only | SubQ injection, IM injection | 2x weekly | ~33 hours |
| Clomiphene | Reports only | Oral tablet | Daily or every other day | ~5 days |
- Evidence
- FDA-approved
- Route
- SubQ injection
- Dosing
- As needed, 1–2 hours before
- Half-life
- ~2.7 hours
- Evidence
- Human studies
- Route
- SubQ injection
- Dosing
- Loading: 250mcg daily for 1-2 weeks. Maintenance: 250-500mcg 2-3x/week or as needed.
- Half-life
- Unknown in humans
- Evidence
- Human studies
- Route
- Oral
- Dosing
- Daily
- Half-life
- ~10 hours
- Evidence
- Human studies
- Route
- SubQ injection
- Dosing
- Pulsatile — 2–3x/week
- Half-life
- ~4 min
- Evidence
- Reports only
- Route
- SubQ injection, IM injection
- Dosing
- 2x weekly
- Half-life
- ~33 hours
- Evidence
- Reports only
- Route
- Oral tablet
- Dosing
- Daily or every other day
- Half-life
- ~5 days
Compared side by side
Guides
Questions
Which peptides have been studied in people for libido and sexual health?
4 of the 6 on this page: PT-141, Melanotan II, Enclomiphene and Kisspeptin-10. The rest have animal or lab evidence or community reports only.
Is any peptide FDA-approved for libido and sexual health?
PT-141: the library records an FDA approval for a related use (PT-141: An FDA-approved, as-needed treatment for low sexual desire in premenopausal women that acts through brain melanocortin receptors rather than blood flow (flibanserin/Addyi is the other, daily option)).
Which is the best-studied peptide for libido and sexual health?
By our count, PT-141, with 2 study pages in people about libido and sexual health, the most of any compound here.
Which ones have only animal or lab evidence for libido and sexual health?
None: every compound on this page has either human evidence for libido and sexual health or community reports only.
How are the peptides for libido and sexual health taken?
Of the 6 compounds for libido and sexual health, 4 are taken by injection, 2 by mouth, as their library entries list (some have more than one route). The table above gives each one’s route, how often it is dosed and its half-life.
How do the peptides for libido and sexual health compare with each other?
We compare 3 pairs of them side by side: PT-141 vs Melanotan II, Clomiphene vs Enclomiphene and HCG vs Clomiphene.
How we ranked them
Each compound is placed on the highest rung its evidence for this goal reaches. First come compounds the FDA has approved for a use related to the goal, and only where the library entry says so. Next come compounds studied in people for it (in one of our study pages, or in the trials a research note of the library entry rests on), then those with animal or lab studies only, and last those resting on community reports alone.
Within a rung, compounds are ordered by how many of our study pages in people cover the goal, then by the library’s overall research rating, then by the number of study pages of any kind. A compound is on this page only because its library entry lists a use for this goal, says so in its description, or one of our study pages is about it; the reason is printed with each one.
This is a ranking of evidence, not of results, and not advice on what anyone should take.